Encapsulated phage for treatment of burns and wound site infections
用于治疗烧伤和伤口部位感染的封装噬菌体
基本信息
- 批准号:EP/I027602/1
- 负责人:
- 金额:$ 83.84万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2011
- 资助国家:英国
- 起止时间:2011 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This project, in partnership with Biocontrol Ltd and the departments of Chemistry and Chemical Engineering at the University of Bath, will encapsulate specific lytic phages within phospholipid vesicles, and incorporate the vesicles into a prototype burn / wound dressing and a topical aqueous cream. The primary focus of the work is in the prevention of infection of paediatric burns, where our clinical partner, Dr Amber Young at the South West Paediatric Burns Centre, Frenchay hospital will provide expertise. The vesicles will be designed such that they both will stabilize the phage over time i.e. when stored, but only release their contents following exposure to secreted toxins and enzymes from pathogenic bacteria. The aim of this project is to reduce the risk of infection from burns and other injuries by making a 'smart' dressing, based on phage therapeutics.38,000 children on average suffer burn injuries in England and Wales each year, of which 55% are scalds. Most are small in area, 80% are in children under five years and the majority are due to hot drink spillages. One of the primary problems in the treatment of burns is bacterial infection, which can delay healing, increase pain; increase the risk of scarring and in some cases cause death. In recent years there have been great improvements in the treatment of burns, particularly with biologically-derived dressings which actively promote cell growth. However, the problem of infection has not gone away, and there is evidence that silver treated antimicrobial dressings can delay burn healing.
该项目与生物控制有限公司和巴斯大学化学与化学工程系合作,将在磷脂囊泡内封装特定的溶解性磷脂,并将囊泡纳入原型烧伤/伤口敷料和局部水性乳膏中。这项工作的主要重点是预防儿科烧伤感染,我们的临床合作伙伴,弗伦谢医院西南儿科烧伤中心的Amber Young博士将提供专业知识。囊泡将被设计成使得它们都将随时间稳定噬菌体,即当储存时,但仅在暴露于来自病原性细菌的分泌毒素和酶之后释放它们的内容物。该项目的目的是通过制造基于噬菌体疗法的“智能”敷料来降低烧伤和其他伤害的感染风险。英格兰和威尔士每年平均有38,000名儿童遭受烧伤,其中55%是烫伤。大多数是小面积,80%是五岁以下的儿童,大多数是由于热饮溢出。烧伤治疗中的主要问题之一是细菌感染,这会延迟愈合,增加疼痛;增加瘢痕形成的风险,并在某些情况下导致死亡。近年来,烧伤的治疗有了很大的改进,特别是生物衍生的敷料,它能积极促进细胞生长。然而,感染的问题并没有消失,有证据表明,银处理的抗菌敷料可以延迟烧伤愈合。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Triggered Release of Bacteriophage K from Agarose/Hyaluronan Hydrogel Matrixes by Staphylococcus aureus Virulence Factors
- DOI:10.1021/cm503974g
- 发表时间:2014-12-23
- 期刊:
- 影响因子:8.6
- 作者:Bean, Jessica E.;Alves, Diana R.;Jenkins, A. Toby A.
- 通讯作者:Jenkins, A. Toby A.
A novel bacteriophage cocktail reduces and disperses Pseudomonas aeruginosa biofilms under static and flow conditions.
- DOI:10.1111/1751-7915.12316
- 发表时间:2016-01
- 期刊:
- 影响因子:5.7
- 作者:Alves DR;Perez-Esteban P;Kot W;Bean JE;Arnot T;Hansen LH;Enright MC;Jenkins AT
- 通讯作者:Jenkins AT
Enhancement of the antimicrobial properties of bacteriophage-K via stabilization using oil-in-water nano-emulsions.
通过使用水包油纳米乳液进行稳定化增强噬菌体-K 的抗菌特性。
- DOI:10.1002/btpr.1898
- 发表时间:2014
- 期刊:
- 影响因子:2.9
- 作者:Esteban PP
- 通讯作者:Esteban PP
Ionized gas (plasma) delivery of reactive oxygen species (ROS) into artificial cells
- DOI:10.1088/0022-3727/47/36/362001
- 发表时间:2014-09-10
- 期刊:
- 影响因子:3.4
- 作者:Hong, Sung-Ha;Szili, Endre J.;Short, Robert D.
- 通讯作者:Short, Robert D.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew Tobias Aveling Jenkins其他文献
Andrew Tobias Aveling Jenkins的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrew Tobias Aveling Jenkins', 18)}}的其他基金
Plasma-activated antimicrobial hydrogel therapy (PAHT) for combating infections in diabetic foot ulcers
等离子体激活抗菌水凝胶疗法 (PAHT) 用于对抗糖尿病足溃疡感染
- 批准号:
EP/V00462X/1 - 财政年份:2021
- 资助金额:
$ 83.84万 - 项目类别:
Research Grant
Development of an infection detecting wound dressing
开发感染检测伤口敷料
- 批准号:
MR/N006496/1 - 财政年份:2015
- 资助金额:
$ 83.84万 - 项目类别:
Research Grant
相似国自然基金
应用噬菌体多肽对食源性金黄色葡萄球菌与肠毒素快速检测的研究
- 批准号:31101276
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
对虾白斑综合症病毒(WSSV)感染相关基因及其细胞受体的筛选和鉴定
- 批准号:30700618
- 批准年份:2007
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
phage display联合基因转染技术对Bcl-2蛋白质结构和功能的研究
- 批准号:30471999
- 批准年份:2004
- 资助金额:8.0 万元
- 项目类别:面上项目
噬菌体展示基因工程人源抗体肿瘤放射免疫显像
- 批准号:30370422
- 批准年份:2003
- 资助金额:20.0 万元
- 项目类别:面上项目
相似海外基金
Advancing Systematic Delivery of Oncolytic Adenovirus for Pancreatic Cancer
推进溶瘤腺病毒治疗胰腺癌的系统递送
- 批准号:
10734709 - 财政年份:2023
- 资助金额:
$ 83.84万 - 项目类别:
Validation of the joint-homing and drug delivery attributes of novel peptides in a mouse arthritis model
在小鼠关节炎模型中验证新型肽的关节归巢和药物递送特性
- 批准号:
10589192 - 财政年份:2023
- 资助金额:
$ 83.84万 - 项目类别:
Nanoluciferase reporter phage for rapid phenotypic characterization of resistance to next-generation antimycobacterial agents
纳米荧光素酶报告噬菌体用于快速表征下一代抗分枝杆菌药物的耐药性
- 批准号:
10593796 - 财政年份:2023
- 资助金额:
$ 83.84万 - 项目类别:
ELUCIDATING THE ROLE OF COATOMER COMPLEX COPI IN SKELETAL DYSPLASIA
阐明 COATOMER 复合物 COPI 在骨骼发育不良中的作用
- 批准号:
10591042 - 财政年份:2023
- 资助金额:
$ 83.84万 - 项目类别:
PROgression of Tuberculosis infECTion in young children living with and without HIV: the PROTECT study
感染和未感染艾滋病毒的幼儿结核感染的进展:PROTECT 研究
- 批准号:
10641389 - 财政年份:2023
- 资助金额:
$ 83.84万 - 项目类别:
Kidney Transplantation from Donors with HIV: Impact on Rejection and Long-term Outcomes
艾滋病毒捐献者的肾移植:对排斥和长期结果的影响
- 批准号:
10704333 - 财政年份:2023
- 资助金额:
$ 83.84万 - 项目类别:
A Potent D-peptide Inhibitor of TNFα for Treatment of Rheumatoid Arthritis
一种有效的 TNFα D 肽抑制剂,用于治疗类风湿性关节炎
- 批准号:
10822182 - 财政年份:2023
- 资助金额:
$ 83.84万 - 项目类别:
Developing an integrated pipeline for routine generation of orthogonal GPCR-targeting nanobodies
开发用于常规生成正交 GPCR 靶向纳米抗体的集成管道
- 批准号:
10603669 - 财政年份:2023
- 资助金额:
$ 83.84万 - 项目类别:
Single domain antibodies for diagnosis and treatment of synucleinopathies
用于诊断和治疗突触核蛋白病的单域抗体
- 批准号:
10915130 - 财政年份:2023
- 资助金额:
$ 83.84万 - 项目类别:
Phage-problem organism dynamics in biological wastewater treatment
废水生物处理中的噬菌体问题生物动力学
- 批准号:
2875485 - 财政年份:2023
- 资助金额:
$ 83.84万 - 项目类别:
Studentship